Biosimilars Saved European Countries €5.7bn Last Year, Says IQVIA Report
Medicines For Europe Urges Further Action To Translate Biosimilar Potential Into Reality
Even countries with low biosimilar usage have benefitted from significant savings • Source: Alamy